SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000902664-19-003717
Filing Date
2019-09-16
Accepted
2019-09-16 08:00:47
Documents
4
Effectiveness Date
2019-09-16

Document Format Files

Seq Description Document Type Size
1 AMAG PHARMACEUTICALS, INC. p19-1904defc14a.htm DEFC14A 198152
2 GRAPHIC image_001.jpg GRAPHIC 4938
3 GRAPHIC image_002.jpg GRAPHIC 4513
4 GRAPHIC image_003.jpg GRAPHIC 4927
  Complete submission text file 0000902664-19-003717.txt   220020
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-10865 | Film No.: 191093796
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 MADISON AVENUE NEW YORK NY 10022
Business Address 520 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A